Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Journey Medical (DERM) Shares Outstanding (2020 - 2026)

Journey Medical filings provide 6 years of Shares Outstanding readings, the most recent being $21.1 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 252.41% to $21.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.1 million, a 252.41% increase, with the full-year FY2025 number at $21.1 million, up 252.41% from a year prior.
  • Shares Outstanding hit $21.1 million in Q4 2025 for Journey Medical, up from $6.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $21.1 million in Q4 2025 to a low of $6.0 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $6.0 million (2021), compared with a mean of $8.7 million.
  • Biggest five-year swings in Shares Outstanding: plummeted 54.97% in 2024 and later skyrocketed 252.41% in 2025.
  • Journey Medical's Shares Outstanding stood at $6.0 million in 2021, then soared by 96.1% to $11.8 million in 2022, then rose by 13.24% to $13.3 million in 2023, then plummeted by 54.97% to $6.0 million in 2024, then skyrocketed by 252.41% to $21.1 million in 2025.
  • The last three reported values for Shares Outstanding were $21.1 million (Q4 2025), $20.4 million (Q3 2025), and $17.5 million (Q2 2025) per Business Quant data.